X0508 4 2024-03-31 0001368514 ADMA BIOLOGICS, INC. ADMA 0002017423 Kestenberg-Messina Kaitlin M. C/O ADMA BIOLOGICS, INC. 5800 PARK OF COMMERCE BLVD. NW, BOCA RATON FL 33487 true COO and SVP, Compliance false Common Stock 2024-03-31 4 F 0 2085 6.6 D 112190 D Common Stock 2024-04-01 4 A 0 192320 0 A 304510 D Stock Option (right to buy) 6.54 2024-04-01 4 A 0 300328 0 A 2034-04-01 Common Stock 300328 300328 D Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of restricted stock units (RSUs). This is not an open market sale of securities. As of the transaction date, represents 112,190 shares of Common Stock acquired pursuant to the vesting of RSUs. These shares represent RSUs that will vest in four equal installments (25% per installment) on each annual anniversary of the date of grant over four years, in each case under the ADMA Biologics, Inc. 2022 Equity Compensation Plan (the "Plan") subject to the reporting person's continued service as of the applicable vesting date. Includes, as of the transaction date, (i) 192,320 RSUs granted on April 1, 2024 and reported on this Form 4, subject to vesting as set forth in footnote (3); and (ii) 112,190 shares acquired pursuant to the vesting of RSUs. The option vests over four years with 25% of the shares underlying the option vesting on the one-year anniversary of the grant date and the remaining 75% of such shares vesting monthly in equal installments over the next three years, becoming fully vested on the four-year anniversary of the grant date. /s/ Kaitlin M. Kestenberg-Messina, by Adam S. Grossman as Attorney-in-fact 2024-04-02